Sir Paul Nurse OM CH FRS presents CMM Sir Anthony Epstein Lecture 2023
The School of Cellular and Molecular Medicine welcomed Sir Paul Nurse OM CH FRS for the Annual Sir Anthony Epstein Lecture.
The School of Cellular and Molecular Medicine welcomed Sir Paul Nurse OM CH FRS for the Annual Sir Anthony Epstein Lecture.
Feeding dogs raw (uncooked) meat increases their risk of excreting E. coli that cannot be killed by a widely used antibiotic - ciprofloxacin - researchers at the University of Bristol have found from a study of 600 healthy pet dogs.
The Little Princess Trust has announced funding of three ground breaking childhood cancer research projects including a new University of Bristol-led study that will investigate how protein production is changed in childhood cancer cells.
As part of our CMM Spotlight Series, PhD students' Dora Bonini and Michaela Gregorova interview Dr Parthive Patel - a Sir Henry Dale Research Fellow in CMM.
Screening has reduced the incidence of bowel cancer finds a new study jointly led by researchers from the University of Bristol and University Hospitals Bristol and Weston NHS Foundation Trust.
Long Covid, which affects nearly two million people in the UK (1), is not caused by an immune inflammatory reaction to COVID-19, University of Bristol-led research finds. Emerging data demonstrates that immune activation may persist for months after COVID-19.
It was fantastic to celebrate with our graduates for the Cellular and Molecular Medicine and Biomedical Sciences programmes along with their families and friends.
On Saturday 10th June, CMM researchers had a stall at the Festival of Nature Barton Hill Family Day. The event was hosted at University of Bristol’s micro-campus site at the Barton Hill Wellspring settlement.
The tail end of May saw researchers Simon Eastham and Will Miller from the School of Cellular and Molecular Medicine involved in organising the Pint of Science festival in Bristol, alongside fellow scientists from across the university.
The School of Cellular and Molecular Medicine has been successful in their application for an Athena Swan Silver Award in April 2023.
The School of Cellular and Molecular Medicine came together on 29 March 2023 to celebrate their latest research news and updates at their Annual Research Away Day.
Using a new computational approach developed to analyse large genetic datasets from rare disease cohorts, researchers at the Icahn School of Medicine at Mount Sinai and colleagues including the University of Bristol, have discovered previously unknown genetic causes of three rare conditions: primary lymphedema (characterised by tissue swelling), thoracic aortic aneurysm disease, and congenital deafness.
Streptococcus pyogenes (also known as the Group A Streptococcus (GAS) or ‘Strep A’) is a bacterial pathogen which can cause a range of diseases from mild (e.g. impetigo, pharyngitis) to severe invasive (e.g. pneumonia, necrotizing fasciitis, sepsis) and severe post infection immune-related conditions (e.g. rheumatic fever, rheumatic heart disease). GAS is estimated to cause over 0.5 million deaths annually, and is one of the top 10 infectious causes of death globally.